The Future of EP Practice Podcast-The Future of EP Practice Video

Video Transcription

Video Summary

At HRX 2026, Dr. James Ip discusses how wearables and patient-recorded ECGs are helping diagnose SVT earlier and guide referrals to electrophysiology. He highlights intranasal atropamil (Cardamyst), an FDA-approved option for patients to self-treat episodes of paroxysmal SVT, with studies showing rapid, effective termination and a favorable safety profile. Researchers are also studying the medication for atrial fibrillation with rapid ventricular response. The speakers envision faster diagnosis, more individualized care, and fewer emergency visits, while noting that ablation remains a definitive treatment option and insurance coverage is still developing.

Keywords

wearables

patient-recorded ECGs

supraventricular tachycardia

intranasal atropamil

atrial fibrillation